Gordon Parry

5.2k total citations · 1 hit paper
49 papers, 3.5k citations indexed

About

Gordon Parry is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Gordon Parry has authored 49 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Immunology. Recurrent topics in Gordon Parry's work include Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Gordon Parry is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Gordon Parry collaborates with scholars based in United States, United Kingdom and Austria. Gordon Parry's co-authors include Mina J. Bissell, H.Glenn Hall, E Y Lee, Andrew P. Spicer, Sandra Gendler, S. Patton, Charlotte S. Kaetzel, John D. Stubbs, Christine Lekutis and U. Srinivasan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gordon Parry

47 papers receiving 3.3k citations

Hit Papers

How does the extracellular matrix direct gene expression? 1982 2026 1996 2011 1982 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon Parry United States 22 1.6k 790 635 581 504 49 3.5k
Richard C. Bates United States 32 2.2k 1.3× 1.6k 2.0× 553 0.9× 568 1.0× 397 0.8× 51 4.3k
Alain B. Schreiber United States 23 2.0k 1.2× 668 0.8× 488 0.8× 560 1.0× 344 0.7× 41 3.4k
David Naor Israel 29 2.0k 1.2× 846 1.1× 1.3k 2.0× 1.3k 2.2× 354 0.7× 136 4.3k
Bjørn R. Olsen United States 28 1.9k 1.2× 641 0.8× 486 0.8× 202 0.3× 492 1.0× 41 3.5k
Hiroshi Shinkai Japan 37 1.1k 0.7× 686 0.9× 792 1.2× 839 1.4× 467 0.9× 153 4.1k
Mark J. Murray United States 24 2.1k 1.3× 845 1.1× 367 0.6× 503 0.9× 558 1.1× 31 4.4k
Chester A. Meyers United States 25 2.2k 1.4× 688 0.9× 370 0.6× 333 0.6× 381 0.8× 46 3.9k
Nancy Boudreau United States 34 2.9k 1.8× 920 1.2× 908 1.4× 482 0.8× 474 0.9× 65 5.4k
Miep Helfrich United Kingdom 43 3.5k 2.1× 2.1k 2.7× 675 1.1× 439 0.8× 538 1.1× 69 6.0k
Richard B. Bankert United States 37 1.6k 1.0× 1.3k 1.7× 357 0.6× 1.9k 3.3× 370 0.7× 138 4.1k

Countries citing papers authored by Gordon Parry

Since Specialization
Citations

This map shows the geographic impact of Gordon Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Parry more than expected).

Fields of papers citing papers by Gordon Parry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Parry. The network helps show where Gordon Parry may publish in the future.

Co-authorship network of co-authors of Gordon Parry

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Parry. A scholar is included among the top collaborators of Gordon Parry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Parry. Gordon Parry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cherkasova, Elena, Rosa Nadal, Long Chen, et al.. (2023). T cell receptor-engineered T cells targeting a human endogenous retrovirus in kidney cancer.. Journal of Clinical Oncology. 41(16_suppl). 4542–4542. 2 indexed citations
2.
Norberg, Scott M., Erika M. von Euw, Gordon Parry, et al.. (2022). A phase I trial of T-cell receptor gene therapy targeting KK-LC-1 for gastric, breast, cervical, lung and other KK-LC-1 positive epithelial cancers.. Journal of Clinical Oncology. 40(16_suppl). TPS2678–TPS2678. 4 indexed citations
3.
Mukherjee, Ali, Ahmed Chenna, Hasan Tahir, et al.. (2011). Profiling the HER3/PI3K Pathway in Breast Tumors Using Proximity-Directed Assays Identifies Correlations between Protein Complexes and Phosphoproteins. PLoS ONE. 6(1). e16443–e16443. 19 indexed citations
5.
Alicke, Bruno, David R. Light, Kirk Mclean, et al.. (2009). In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of 86Y- and 111In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor–Bearing Nude Mice. Journal of Nuclear Medicine. 50(3). 435–443. 62 indexed citations
6.
Dua, Rajiv, et al.. (2009). EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance. Breast Cancer Research and Treatment. 122(3). 685–697. 66 indexed citations
7.
Johnson, Paul H., Roger P. Walker, Steven W. Jones, et al.. (2002). Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells.. PubMed. 1(14). 1293–304. 53 indexed citations
8.
Ellem, K.A.O., Michael G. E. OʼRourke, Gregory R. Johnson, et al.. (1997). A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy. Cancer Immunology Immunotherapy. 44(1). 10–20. 72 indexed citations
9.
Dahl, Niklas, M. William Lensch, P. F. Chance, et al.. (1995). New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology. 45(10). 1863–1866. 61 indexed citations
10.
Jaffee, Elizabeth M., R. M. Mulligan, Drew M. Pardoll, et al.. (1994). Feasibility of human gene therapy for renal cell carcinoma. 486.
11.
Packard, Beverly Z. & Gordon Parry. (1994). Bone marrow activation by immobilized antibodies against tumor cells and immunocytes as a potential cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1224(3). 395–400. 1 indexed citations
12.
Beck, James C., Christine Lekutis, John Couchman, & Gordon Parry. (1993). Stage-Specific Remodeling of the Mammary Gland Basement Membrane During Lactogenic Development. Biochemical and Biophysical Research Communications. 190(2). 616–623. 7 indexed citations
13.
Shyamala, Gopalan, et al.. (1991). Molecular cloning, sequence analyses, and expression of complementary DNA encoding murine progesterone receptor. Biochemistry. 30(28). 7014–7020. 79 indexed citations
14.
Shy, Michael E., et al.. (1990). Lower motor neuron disease in a patient with auto‐antibodies against Gal(β 1‐3)GalNAc in gangliosides GM 1 and GD 1b. Neurology. 40(5). 842–842. 49 indexed citations
15.
16.
Tk, Hunt, et al.. (1989). MHC antigens persist on human fetal pancreatic islet cells even after culture and transplantation into nude mice.. PubMed. 21(1 Pt 3). 2653–6. 2 indexed citations
17.
Barcellos‐Hoff, Mary Helen, et al.. (1987). Transferrin is a major mouse milk protein and is synthesized by mammary epithelial cells. In Vitro Cellular & Developmental Biology - Plant. 23(3). 221–226. 49 indexed citations
18.
Lee, E Y, et al.. (1985). Interaction of mouse mammary epithelial cells with collagen substrata: regulation of casein gene expression and secretion.. Proceedings of the National Academy of Sciences. 82(5). 1419–1423. 228 indexed citations
19.
20.
Parry, Gordon, et al.. (1977). Topography and mobility of ribosomes on the surface of isolated endoplasmic reticulum of rat liver. Journal of Molecular Biology. 109(4). 589–592. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026